Bempedoic acid for LDL cholesterol

被引：0
|
作者：
McIntosh, Kate V.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2019年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [21] Bempedoic acid
    Oroko, Maroria
    Fisher, Miles
    PRACTICAL DIABETES, 2022, 39 (01) : 42 - +
  • [22] Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology
    Patti, Giuseppe
    Cavallari, Ilaria
    Cesaro, Arturo
    Gragnano, Felice
    Riva, Letizia
    Fimiani, Fabio
    Cuccia, Claudio
    Fresco, Claudio
    Calabr, Paolo
    Leonardi, Sergio
    Marcucci, Rossella
    Rubboli, Andrea
    VASCULAR PHARMACOLOGY, 2023, 148
  • [23] Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
    Katzmann, Julius L.
    Becker, Christian
    Bilitou, Aikaterini
    Laufs, Ulrich
    PLOS ONE, 2022, 17 (10):
  • [24] PHASE 3 EVALUATION OF BEMPEDOIC ACID ADDED TO EZETIMIBE IN PATIENTS WITH ELEVATED LDL-CHOLESTEROL RECEIVING NO GREATER THAN LOW DOSE STATINS: CLEAR TRANQUILITY
    Ballantyne, Christie M.
    Banach, Maciej
    Mancini, G. B. John
    Lepor, Norman E.
    Hanselman, Jeffrey C.
    Zhao, Xin
    Leiter, Lawrence A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 25 - 25
  • [25] Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)
    Agha, Ali M.
    Jones, Peter H.
    Ballantyne, Christie M.
    Virani, Salim S.
    Nambi, Vijay
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (05) : 649 - 652
  • [26] Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
    Ballantyne, Christie M.
    Bays, Harold E.
    Louie, Michael J.
    Smart, Jeremy
    Zhang, Yang
    Ray, Kausik K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (15):
  • [27] A Newly Approved Cholesterol Drug Joins the Lipid-Lowering Arsenal: Bempedoic Acid
    Furer, Joseph
    Popova, Olga
    Plakogiannis, Roda
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (10): : 722 - 725
  • [28] Meta Analysis of Efficacy and Safety of Bempedoic Acid in Lowering Low Density Lipoprotein Cholesterol
    Khan, Muhammad U.
    Khan, Safi U.
    Khan, Muhammad
    Lone, Ahmad Naeem
    Valavoor, Shahul
    Raghu, Charumathi
    Arshad, Adeel
    Talluri, Swapna
    Alkhouli, Mohamad Adnan
    CIRCULATION, 2019, 140
  • [29] Bempedoic acid for the treatment of hypercholesterolemia
    Yang, Junyi
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (07) : 373 - 380
  • [30] Bempedoic Acid Lowers Low Density Lipoprotein-Cholesterol and Attenuates Aortic Atherosclerosis in LDL Receptor-Deficient (LDLR+/- and LDLR-/-) Yucatan Miniature Pigs
    Burke, Amy C.
    Telford, Dawn E.
    Sutherland, Brian G.
    Edwards, Jane Y.
    Sawyez, Cynthia G.
    Newton, Roger S.
    Huff, Murray W.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
12345